Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Respiri Limited (RSHUF)
OTHER OTC:RSHUF
Holding RSHUF?
Track your performance easily
RSHUF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.03
Previous Close$0.01
Volume1.00K
Average Volume (3M)N/A
Market Cap
$26.09M
Enterprise Value$25.32M
Total Cash (Recent Filing)AU$1.22M
Total Debt (Recent Filing)AU$70.66K
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.53
R-Squared0.00558
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)290.78
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Respiri Limited News
PremiumCompany Announcements
Respiri Limited Affirms Corporate Governance Compliance
PremiumCompany Announcements
Respiri Limited Strikes Major eHealth Partnership
PremiumCompany Announcements
Respiri Limited Reports Surge in FY24 Growth
PremiumCompany Announcements
Respiri Limited Expands Market PresencePremiumCompany Announcements
Respiri Limited Expands Market Presence
PremiumCompany Announcements
Respiri Limited Expands Market Presence with New ASX Shares
PremiumCompany Announcements
Respiri Limited Eyes Profitability in 2024
PremiumCompany Announcements
Respiri Limited Extends Offer Period in UpdateOptions Prices
Currently, No data available
---
Ownership Overview
19.78% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
80.22% Public Companies and
Individual Investors
RSHUF FAQ
What was Respiri Limited’s price range in the past 12 months?
Respiri Limited lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is Respiri Limited’s market cap?
Currently, no data Available
When is Respiri Limited’s upcoming earnings report date?
Respiri Limited’s upcoming earnings report date is Feb 26, 2025 which is in 159 days.
How were Respiri Limited’s earnings last quarter?
Respiri Limited released its earnings results on Aug 27, 2024. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
Is Respiri Limited overvalued?
According to Wall Street analysts Respiri Limited’s price is currently Overvalued.
Does Respiri Limited pay dividends?
Respiri Limited does not currently pay dividends.
What is Respiri Limited’s EPS estimate?
Respiri Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Respiri Limited have?
Respiri Limited has 1,284,768,900 shares outstanding.
What happened to Respiri Limited’s price movement after its last earnings report?
Respiri Limited reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Respiri Limited?
Currently, no hedge funds are holding shares in RSHUF
---
Respiri Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
RSHUF Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-421.90%
Trailing 12-Months
Asset Growth
95.25%
Trailing 12-Months
Company Description
Respiri Limited
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. It operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.
---
Technical Analysis
---